AGT and triple-A syndrome: Wang et al. reported that a relatively low dose of NFB (1.0 mg/kg/day) alone promoted AAA formation in mice infused with AngII [15], which contrasts to our finding that a much higher dose of NFB (i.e., 45.0 mg/kg/day) was unable to affect TAAD formation.